Novartis bets $1.6bn on inflammation-focused biotech
Novartis to acquire IFM Tre to gain access to one clinical and two pre-clinical assets, which are designed to combat chronic inflammatory conditions.
Novartis to acquire IFM Tre to gain access to one clinical and two pre-clinical assets, which are designed to combat chronic inflammatory conditions.
Horizon Discovery is working with St George’s University Hospital and EMQN to develop reference material for non-invasive prenatal testing, which is being increasingly adopted in the UK and abroad.
The EMA issues advice on the composition of season flu vaccines for the 2019/2020 season for manufacturers.
Clinerion continues to expand its Patient Network Explorer platform with the most recent addition of Sigmasoft, an EHR provider based in Greece.
Sinclair Research and Turner Scientific sign an exclusive partnership through which the CROs will offer ototoxicity testing services – and improve regulatory guidance regarding the ears to protect patients, says company executive.
Cell One Partners formally launches its consulting services and aims to be a long-term partner to its clients, supporting the development of cell and gene therapies – a market which raised more than $13.3bn in 2018.